Cargando…
Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection
The highly glycosylated glycoprotein spike of Ebola virus (EBOV-GP(1,2)) is the primary target of the humoral host response. Recombinant EBOV-GP ectodomain (EBOV-GP(1,2ecto)) expressed in mammalian cells was used to immunize sheep and elicited a robust immune response and produced high titers of hig...
Autores principales: | Dowall, Stuart David, Callan, Jo, Zeltina, Antra, Al-Abdulla, Ibrahim, Strecker, Thomas, Fehling, Sarah K., Krähling, Verena, Bosworth, Andrew, Rayner, Emma, Taylor, Irene, Charlton, Sue, Landon, John, Cameron, Ian, Hewson, Roger, Nasidi, Abdulsalami, Bowden, Thomas A., Carroll, Miles W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779302/ https://www.ncbi.nlm.nih.gov/pubmed/26715676 http://dx.doi.org/10.1093/infdis/jiv565 |
Ejemplares similares
-
Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic
por: Dowall, Stuart D., et al.
Publicado: (2016) -
Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product
por: Dowall, Stuart D., et al.
Publicado: (2017) -
Toremifene interacts with and destabilizes the Ebola virus glycoprotein
por: Zhao, Yuguang, et al.
Publicado: (2016) -
Emerging Paramyxoviruses: Receptor Tropism and Zoonotic Potential
por: Zeltina, Antra, et al.
Publicado: (2016) -
Investigating the Cellular Transcriptomic Response Induced by the Makona Variant of Ebola Virus in Differentiated THP-1 Cells
por: Bosworth, Andrew, et al.
Publicado: (2019)